Congress is not going to get involved in the McGwire business

Leave a comment

I only mention this because, just like the will-Bonds-be-the-next-to-apologize thing, tons of people are asking me if I think Congress will get back into the steroids thing in light of Mark McGwire’s admission.

No and no.

The first no is based on the legalities involved. The only reason they’d have to haul McGwire back or to have him investigated or what have you is for perjury. Anyone who spent any time looking back at the tapes of McGwire’s 2005 testimony, however, quickly realizes that there’s no basis for even the suggestion of perjury. He didn’t say anything. If there was any hope at all that he’d be legally scrutinized over his statements, that hope was dashed when the House committee refused to follow up or compel him to either testify or take the Fifth Amendment.   You can view this one of two ways: (1) Congress abdicating its duty to find the facts it purported to be trying to find that day; or (2) Congress tacitly acknowledging that the purpose of that hearing was grandstanding and nothing more. Either way, the ship has sailed.

The second no comes from the statements of the two men in charge of that hearing, Committee chair Tom Davis and ranking Democrat Henry Waxman.  First Davis:

”He looked ridiculous to most of the public, but he didn’t have many
good options. We put him in a pretty tight spot. He was candid and
honest in our interrogation of him.”

Some interrogation. I’ve seen Larry King get tougher on a Gabor sister.  Here’s Waxman:

“Mark McGwire is doing the right thing by telling the truth about his
steroid use. His statement sends an important message to kids about the
importance of avoiding steroids.”

Congress should never have gotten involved in this in the first place. They did anyway, but at least now, at long last, they realize that it’s time to stay out of it.

Royals sign Drew Storen to minor league deal

Drew Storen
Getty Images
Leave a comment

The Royals are in agreement with right-handed reliever Drew Storen on a minor league deal, the team announced Friday. Per Jon Heyman of MLB Network, the deal is worth $1.25 million if the veteran righty breaks camp with the club this spring. Additional, albeit unspecified incentives will be included in the contract as well.

Storen, 31, is coming off of a protracted absence from any MLB duties. After inking a one-year deal with the Reds in 2017, he sustained a right elbow sprain toward the end of the year and underwent Tommy John surgery that October. He was effectively decommissioned for the club’s entire 2018 run and generated little interest around the league this winter, perhaps due in part to the uninspired 4.45 ERA, 3.8 BB/9, 7.9 SO/9, and career-low -0.2 fWAR he posted across 54 2/3 innings during his last healthy season.

While it’s not immediately clear what kind of performance the Royals can expect from Storen in spring training, they’re not exactly in a position to be choosy. Their bullpen ranked dead last among all MLB teams with a collective 5.04 ERA, 4.85 FIP, and -2.2 fWAR last year, and still appears to be in a state of flux as they approach Opening Day. Skipper Ned Yost told reporters Wednesday that he intends to eschew the traditional closer appointment in 2019 and will instead utilize a combination of right-handers Wily Peralta and Brad Boxberger, lefty Tim Hill, and various others as he tackles high-leverage situations in the future.